Healthcare giant Johnson & Johnson is to stop selling its talc-based Johnson’s Baby Powder in the US and Canada.
The firm faces many thousands of lawsuits from consumers who claim that its talc products caused their cancer.
The move comes after years of litigation where Johnson & Johnson has been ordered to pay out billions of dollars in compensation.
The company has consistently defended the safety of its talc products.
Johnson & Johnson said it would wind down sales of the product, which makes up about 0.5% of its US consumer health business, in the coming months, but that retailers would continue to sell existing inventory.
The firm faces more than 16,000 consumer lawsuits alleging that the company’s talc products were contaminated with asbestos, a known carcinogen.
In October, Johnson & Johnson announced a voluntary recall in the US of a single lot of its Johnson’s Baby Powder in response to a US Food and Drug Administration (FDA) test indicating the presence of sub-trace levels of asbestos in samples from a single bottle purchased from an online retailer.
Subsequently, the company reported that tests conducted by two third-party labs show asbestos was not present in the single bottle that FDA’s contracted lab, AMA Analytical Services, Inc tested.
The firm is appealing against a 2018 order to pay $4.7bn (£3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer.
JNJ short (Sell)
Enter at: 147.94